|
Kidney/Liver Cancer
 including cholangiocarcinoma and cystadenocarcinoma; hepatoblastoma; mesenchymal and renal carcinomas.
 Products contained on this page available in special bundle, incl. free technical support.
 ancers of the liver and kidney are relatively rare compared to others mentioned herein. Found more often in men than women, risk of liver cancer greatly increases when a subject has had hepatitis B or C, or cirrhosis. Kidney cancer is a little more common, and later stage symptoms are quite specific: blood in the urine; a lump or mass in the kidney areas. A qualified urologist provides the best source of diagnosis.
In accordance with prevailing "food and drug" law in some of the countries in which we conduct business, most notably the U.S. and U.K., we wish to make clear that the "nutritional support" products we design and recommend are NOT offered as a treatment or cure for this, or any other cancer type. (Read disclaimer: right column.) Our testimonial cancer pages are republished only as a guide to what others have experienced in the course of using our products.
Currently, the regimen we offer for nutritional support of primary and secondary breast cancers is as follows: (1) Cansema Tonic III, (2) CanSupport - Breast, and (3) HRx Concentrate (for use as drinking water, in tea and coffee - to make the system less acidic during Cansema/CanSupport usage). These three products should be taken concurrently. Also very potent is our anti-tumor device to shrink tumors.
Note: This information is provided for educational purposes only and is not intended to replace the use of a qualified health care professional. We strongly recommend the use of a physician for the diagnostic phase of any treatment. With an accurate diagnosis in hand, we believe the consumer, at that point, has a basic, unalienable right to seek out factual information on all therapeutic approaches, both orthodox and alternative, and choose those approach(es) that are right for them. Nonetheless, a "good doctor" should be considered a requisite starting point.
Liver Cancer: Who's at Risk?
Cancer of the liver is a rare malignancy in the United States, but in parts of Asia and Africa, it is one of the most common malignancies. In the United States, the average age on onset is 60 to 70 years; the disease occurs more frequently in males than females. There is a strong association between chronic hepatitis B infection and the development of heptaocellular carcinoma. People with cirrhosis also have an increased risk of liver cancer. Other possible hepatocarcinogens include aflatoxin, nitrosamines, oral estrogen compounds, and numerous other chemicals.
|